CHIH


MSCI China Health Care ETF

Reasons to Consider CHIH

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Key Information As of 07/01/22

Inception Date 12/07/18
Total Expense Ratio 0.65%
Net Assets $12.55 million
NAV $17.43
Fact Sheet

ETF Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

ETF Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Trading Details As of 07/01/22

Ticker CHIH
Bloomberg Index Ticker NU722071
CUSIP 37954Y541
ISIN US37954Y5419
Primary Exchange NYSE Arca
Shares Outstanding 720,002
Number of Holdings 82
30-Day Median Bid-Ask Spread 1.87%

Distributions As of 07/01/22

30-Day SEC Yield 0.08%
Distribution Frequency Semi-Annually

ETF Prices As of 07/01/22

NAV $17.43 Daily Change $0.07 0.37%
Market Price $17.43 Daily Change -$0.10 -0.56%

Performance History

As of recent
(03/31/22)
As of recent
(03/31/22)
Fund NAV Market Price Index
1 Year -36.34% -37.24% -35.97%
3 Years 1.48% 0.78% 2.23%
Since Inception 5.07% 4.74% 5.83%
1 Year -51.56% -52.13% -52.63%
3 Years 0.18% -0.30% 0.91%
Since Inception 0.97% 0.73% 1.69%
Year-to-Date -19.30% -19.98% -19.20%
1 Month -6.41% -7.52% -6.39%
3 Months -19.30% -19.98% -19.20%
Since Inception 17.82% 16.61% 20.65%
Year-to-Date -29.16% -29.63% -29.00%
1 Month -1.35% 0.00% -1.30%
3 Months -17.84% -18.67% -17.74%
Since Inception 3.43% 2.55% 6.02%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 07/01/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
10.44 2269 HK WUXI BIOLOGICS CAYMAN INC BL6B9P1 9.15 143,180 1,310,121.13
6.87 1093 HK CSPC PHARMACEUTI 6191997 0.99 868,808 862,513.53
5.88 BGNE BEIGENE LTD-ADR BYYWPW6 166.95 4,421 738,085.95
5.21 1177 HK SINO BIOPHARMACEUTICAL B00XSF9 0.63 1,032,300 653,833.19
3.84 1801 HK INNOVENT BIOLOGICS INC BGR6KX5 4.45 108,400 482,124.67
3.57 2359 HK WUXI APPTEC CO LTD-H BGHH0L6 13.32 33,656 448,211.96
3.50 1548 HK GENSCRIPT BIOTECH CORP BD9Q2J2 3.63 121,000 438,704.70
2.87 1099 HK SINOPHARM GROUP CO-H B3ZVDV0 2.42 148,500 359,949.53
2.58 300760 C2 SHENZHEN MINDR-A BHQK864 46.50 6,961 323,719.67
2.52 ZLAB ZAI LAB LTD-ADR BD9GVY0 38.54 8,190 315,642.60
2.44 1066 HK SHANDONG WEIG-H 6742340 1.16 263,300 306,020.38
2.08 3692 HK HANSOH PHARMACEU BJYKB72 2.02 129,300 261,010.72
2.01 867 HK CHINA MEDICAL SY B6WY993 1.56 161,300 251,605.68
2.00 300015 C2 AIER EYE HSPTL-A BD5CLQ4 6.51 38,524 250,612.55
1.99 603259 C1 WUXI APPTEC CO LTD-A BHWLWV4 15.32 16,324 250,096.08
1.95 LEGN LEGEND BIOTECH CORP-ADR BMX9K07 55.84 4,383 244,746.72
1.95 600276 C1 JIANGSU HENGRU-A BP3R369 5.78 42,272 244,313.68
1.93 600436 C1 ZHANGZHOU PIEN-A BP3R7Z6 52.28 4,626 241,839.73
1.90 570 HK TRAD CHI MED 6971779 0.62 385,600 238,332.58
1.73 6078 HK HYGEIA HEALTHCAR BMX09H0 6.65 32,600 216,658.91
1.66 2196 HK FOSUN PHARMA-H B8XBQ96 3.70 56,400 208,799.71
1.60 853 HK MICROPORT SCIENTIFIC CORP B676TW7 2.90 69,200 200,628.28
1.54 3759 HK PHARMARON BEIJ-H BK72QD3 10.01 19,275 192,950.20
1.40 300122 C2 CHONGQING ZHIF-A BD5CJY8 16.98 10,333 175,495.53
1.39 2607 HK SHANGHAI PHARM-H B4Q4CJ6 1.66 105,400 174,617.84
1.13 1530 HK 3SBIO INC BY9D3L9 0.80 178,700 142,106.45
1.08 3347 HK HANGZHOU TIGER-H BMZC7F8 11.56 11,720 135,468.88
1.08 000538 C2 YUNNAN BAIYAO-A BD5CP95 8.94 15,114 135,173.09
1.08 HCM HUTCHMED CHINA-ADR BYXV9H7 13.45 10,037 134,997.65
1.07 1951 HK JINXIN FERTILITY BJ9JY53 0.92 145,200 133,785.66
1.07 000963 C2 HUADONG MEDICINE CO LTD-A BD5CM94 6.68 20,011 133,608.47
0.83 600196 C1 SHANGHAI FOSUN-A BP3R3M5 6.86 15,274 104,712.33
0.81 300896 C2 IMEIK TECHNOLO-A BNR4MY3 88.07 1,160 102,165.26
0.74 000661 C2 CHANGCHUN HIGH-A BD5CDB3 34.14 2,728 93,128.11
0.73 6185 HK CANSINO BIOLOGICS INC-H BJKDJS2 10.24 8,900 91,134.02
0.67 300142 C2 WALVAX BIOTECHNOLOGY CO-A BD5CG36 7.24 11,700 84,656.89
0.67 300347 C2 HANGZHOU TIGER-A BD5CCK5 17.18 4,916 84,475.03
0.67 600332 C1 GUANGZHOU BAIY-A BP3R4Q6 4.61 18,159 83,733.54
0.65 300759 C2 PHARMARON BEIJ-A BK4XYC4 14.27 5,700 81,330.88
0.63 603392 C1 BEIJING WANTAI-A BMXTWX4 23.17 3,390 78,532.55
0.61 002001 C2 ZHEJIANG NHU CO LTD-A BD5CH66 3.33 22,968 76,470.43
0.54 002821 C2 ASYMCHEM LABOR-A BD6V5C4 42.33 1,613 68,278.78
0.46 600763 C1 TOPCHOICE MEDI-A BYYFJH8 25.48 2,280 58,095.43
0.42 601607 C1 SHANG PHARM -A BP3R4Z5 2.68 19,500 52,282.09
0.41 002422 C2 SICHUAN KELUN-A BD5CL08 2.79 18,500 51,586.10
0.41 300601 C2 SHENZHEN KANGT-A BFY8HT2 6.65 7,748 51,558.26
0.40 002294 C2 SHENZHEN SALUBRIS PHARM-A BD5CM05 4.16 12,200 50,692.04
0.39 002007 C2 HUALAN BIOLOGI-A BD5CL19 3.45 14,070 48,543.63
0.38 000423 C2 DONG-E-E-JIAOCO LTD-A BD5CM61 5.42 8,800 47,673.20
0.37 002603 C2 SHIJIAZHUANG Y-A BD5CHJ9 3.56 13,027 46,401.23
0.37 300595 C2 OVCTEK CHINA INC-A BHQPSJ2 8.34 5,524 46,078.27
0.36 603858 C1 SHANDONG BUCHA-A BYW5NC3 2.92 15,487 45,146.42
0.35 600998 C1 JOINTOWN PHARMACEUTICAL-A BP3R541 1.77 24,870 44,033.12
0.35 000999 C2 CHINA RESOURCE-A BD5CL42 6.76 6,500 43,941.37
0.35 688180 C1 SHANGHAI JUNSH-A BLCD7F7 11.03 3,955 43,617.96
0.34 300529 C2 JAFRON BIOMEDI-A BFY8H03 7.53 5,700 42,899.62
0.32 002044 C2 MEINIAN ONEHEA-A BD73L10 0.82 49,420 40,361.80
0.31 688363 C1 BLOOMAGE BIOTE-A BP91NT8 20.78 1,890 39,274.01
0.31 300003 C2 LEPU MEDICAL TECHNOLOGY-A BD5CM16 2.80 13,901 38,927.81
0.31 603882 C1 GUANGZHOU KING-A BFYX689 12.43 3,100 38,545.27
0.29 603456 C1 ZHEJIANG JIUZH-A BMQBVL8 7.49 4,900 36,710.66
0.28 002252 C2 SHANGHAI RAAS -A BD5CPJ5 0.89 39,800 35,292.89
0.27 600161 C1 BEIJING TIAN-A BP3R9J4 3.57 9,600 34,266.04
0.26 603127 C1 JOINN LABORATO-A BK94819 17.15 1,900 32,592.38
0.25 600521 C1 ZHEJIANG HUAHA-A BP3RBR6 3.35 9,310 31,191.28
0.24 603707 C1 NANJING KING-F-A BF2DZL7 4.17 7,336 30,612.90
0.23 688202 C1 SHANGHAI MEDICILON INC-A BNR4NV7 49.78 589 29,318.99
0.23 300676 C2 BGI GENOMICS CO LTD-A BFY8H58 10.57 2,733 28,882.47
0.22 300832 C2 SHENZHEN NEW-A BMXTX20 6.75 4,000 26,999.11
0.20 300357 C2 ZHEJIANG WOLWO-A BFY8GY0 7.49 3,423 25,634.81
0.20 CASH 1.00 24,951 24,937.10
0.19 002223 C2 JIANGSU YUYUE-A BD5CJM6 3.89 6,200 24,116.78
0.18 600079 C1 HUMANWELL HEAL-A BP3R712 2.37 9,700 22,985.61
0.18 688185 C1 CANSINO BIOLOGICS INC-A BMD9JD3 29.13 773 22,518.88
0.18 000739 C2 APELOA PHARMA-A BD5LY17 3.13 7,100 22,252.81
0.18 002030 C2 DAAN GENE CO LTD-A BD5CKW3 2.56 8,560 21,942.67
0.17 300558 C2 BETTA PHARMACE-A BD6QWL7 8.30 2,620 21,745.31
0.17 600380 C1 JOINCARE PHARM-A BP3RBV0 1.84 11,700 21,569.63
0.17 000513 C2 LIVZON PHARM-A BD5CQ25 5.35 3,900 20,860.53
0.15 300253 C2 WINNING HEALTH-A BD5CKZ6 1.31 14,470 18,891.21
0.14 688298 C1 ZHEJIANG ORIEN-A BNR4NX9 16.78 1,027 17,234.39
0.12 300677 C2 INTCO MEDICAL-A BMTCVT6 3.70 4,140 15,307.85
0.01 IMAB I-MAB-SPONSORED ADR BKRRKY7 11.49 100 1,149.00
Holdings are subject to change.

ETF Characteristics As of 07/01/22

Return on Equity 9.80%
Weighted Avg. Market Cap 16,356 M
2021 2022
Price-to-earnings 38.39 33.13
Price-to-book value 3.37 3.16

Source: AltaVista Research, LLC

ETF Risk Stats As of 07/01/22

Versus Beta
S&P 500 0.29
MSCI EAFE 0.30
MSCI Emg. Mkts 0.68
Standard Deviation 28.00%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.

Back to Top